当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Belgin Sarper Can and Asiye Durmaz Akyol
Objective: Chronic liver disease affects physical, psychological, social, economic problems and medical side effects in different levels. Because of these problems, the specific nature of a disease is best evaluated by a specific instrument. Specific instruments provide for nurses to capture the specific status of disease and make specific interventions to client and disease. Design: A cross-sectional and methodological design. Methods: The study data was collected from 170 patients with chronic liver disease. The validity of the instrument was examined with translation procedures, face validity, construct validity and concurrent validity. The reliability of instrument was examined with test-retest reliability and internal consistency. Results: It showed that factor analysis consisted of 3 levels which are Physical Health, Mental Health, and Social/Cognitive health. A negative relation was found between the mean score of CTP and the mean score of instrument (r=− 0.26, p<0.001). The test-retest reliability of instrument was found as 0.94 (ICC) p<0.01. The internal consistency Cronbach Alfa Coefficient of LDQOL 1.0 had good level and it was 0.80. Conclusion: At the end of study “LDQOL 1.0” was found that it is very reliable and a valid instrument for Turkish society in chronic liver disease.